Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artemisia frigida pollen extract is a biological product derived from the pollen of the prairie sagebrush plant (*Artemisia frigida*). It is an injectable solution primarily used as an allergenic extract for diagnostic purposes. Administered via skin prick testing, it is used to diagnose allergies to *Artemisia frigida* pollen by inducing a localized hypersensitivity reaction in sensitized individuals. This type of extract was first approved in the U.S. in 1965. While mainly a diagnostic tool, allergenic extracts from Artemisia species are also used in allergen immunotherapy to treat pollen allergies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on artemisia frigida pollen extract.